Genomic and Transcriptomic Profiling of Radiation-Resistant, Locally Recurrent Prostate Cancer

By afschroeder • October 20, 2025

Neilsen BK, Huang RR, Valle LF, Proudfoot JA, Davicioni E, Zhang L, Ryg U, Schulz-Jaavall M, Weidhaas JB, Santoso M, Parmisano S, Calais J, Reiter RE, Rettig MB, Steinberg ML, Sisk A, Brisbane W, Marks LS, Boutros PC, Lilleby WH, Kishan AU. Genomic and Transcriptomic Profiling of Radiation-Resistant, Locally Recurrent Prostate Cancer. Int J Radiat Oncol Biol Phys. 2025 Sep 29:S0360-3016(25)06298-4. doi: 10.1016/j.ijrobp.2025.09.035. Epub ahead of print. PMID: 41105052.

Tags: Hematology/Oncology, Publications, Veterans Administration

Related Posts

The Randomized Phase 2 ARC-9 Study of Etrumadenant-Based Therapy vs Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer

Cecchini M, Han SW, Lee S, Lee KW, Kopetz S, Mizrahi J, Hong YS, Ghiringhelli F, Italiano A, Tougeron D, Beagle B, Boakye M, Zhao[...]

Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia

Rugo HS, Tolaney SM, Cortés J, Marmé F, de Azambuja E, Xu B, Sohn J, Naito Y, Valdez T, Gary D, Zhu J, Lai C,[...]

Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering

Chen X, Mao Z, Kolawole EM, Persechino M, Jude KM, Ogishi M, Mo KC, McLaughlin J, Cheng D, Xiang X, Yang X, Gee C, Liu[...]